Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
![Medchemexpress LLC 5-Pyrimidinecarboxamide, N-(2-chloro-6-methylphenyl)-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-...](https://assets.fishersci.com/TFS-Assets/CCG/product-images/default.jpg-650.jpg)
Medchemexpress LLC 5-Pyrimidinecarboxamide, N-(2-chloro-6-methylphenyl)-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-... | 2556836-50-9 | 98.6% | 597.11 | 100 MG
Supplier: Medchemexpress LLC HY136605100MG
DGY-06-116 is an irreversible covalent and selective Src inhibitor with an IC50 of 3 nM. It demonstrates potent antiproliferative effects in non-small cell lung cancer (NSCLC) and triple-negative breast cancer (TNBC) cell lines, effectively inhibiting Src kinase activity and signaling.
- Irreversible covalent and selective Src inhibitor
- Potent antiproliferative effects in various cancer cell lines
- Induces potent Src binding and inhibition of Src signaling
- Effective in vivo inhibition of Src with a short half-life
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?